TABLE 4.
Omicron infection self-reported disease severity assessed by questionnaire results in RTRs, stratified by preinfection fourth BNT162b2 vaccination status
| Variable, n (%) | Total cohort (N = 137) | Fourth vaccine administered (N = 68) | No fourth vaccine (N = 69) | P |
|---|---|---|---|---|
| Hospitalization | 7 (5.1) | 3 (4.4) | 4 (5.7) | 0.73 |
| Fever | 51 (37.2) | 20 (29.4) | 31 (44.9) | 0.06 |
| Chills | 45 (32.8) | 15 (22.1) | 30 (43.5) | 0.008** |
| Cough | 80 (58.4) | 34 (50) | 46 (66.7) | 0.048* |
| Sore throat | 46 (33.6) | 19 (27.9) | 27 (39.1) | 0.16 |
| Headache | 55 (40.1) | 23 (33.8) | 32 (46.4) | 0.13 |
| Fatigue/weakness | 78 (56.9) | 32 (47.1) | 46 (66.7) | 0.02* |
| Myalgia | 57 (41.6) | 23 (33.8) | 34 (49.3) | 0.06 |
| Nausea/vomiting | 12 (8.7) | 2 (2.9) | 10 (14.5) | 0.02* |
| Abdominal pain/diarrhea | 22 (16) | 5 (7.4) | 17 (24.6) | 0.006** |
| Back pain | 31 (22.6) | 12 (17.6) | 19 (27.5) | 0.17 |
| Loss of smell and taste | 18 (13.1) | 6 (8.8) | 12 (18.8) | 0.09 |
| N = 134 | N = 66 | N = 68 | ||
| Disease severity | ||||
| Mild | 86 (64.2) | 52 (78.8) | 37 (54.4) | 0.008** |
| Moderate | 21 (15.7) | 8 (12.1) | 13 (19.1) | |
| Severe | 24 (17.9) | 6 (9.1) | 18 (26.5) | |
| Received treatment | 31 (23.1) | 19 (28.8) | 12 (17.6) | 0.11 |
*P < 0.05; **P < 0.01.
RTR, renal transplant recipient.